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Abstract
Population level evolutionary processes can occur within a single organism when the germ line contains a mutation that
confers a cost at the level of the cell. Here we describe how multiple compensatory mutations arose through a within-
individual evolutionary process in two brothers with the immune deficiency Wiskott-Aldrich Syndrome (WAS). As a result,
both brothers have T lymphocyte populations that are highly polymorphic at the locus of the germ line defect, and no
single allele achieves fixation. WASP, the gene product affected in this disease, is specific to white blood cells where it is
responsible for regulating actin cytoskeleton dynamics in a wide range of cellular responses. The brothers inherited a rare
allele predicted to result in truncated WASP lacking the carboxy-terminal VCA domains, the region that directly catalyzes
actin filament generation. Although the brothers’ T cell populations are highly polymorphic, all share a corrective effect
relative to the inherited allele in that they restore the VCA domain. This indicates massive selection against the truncated
germ line allele. No single somatic allele becomes fixed in the circulating T cell population of either brother, indicating that a
regulated step in maturation of the affected cell lineage is severely compromised by the germ line allele. Based on the
finding of multiple somatic mutations, the known maturation pathway for T-lineage cells and the known defects of T cells
and precursor thymocytes in mice with truncated WASP, we hypothesize that the presence of truncated WASP (WASPDVCA)
confers an extreme disadvantage in early developing thymocytes, above and beyond the known cost of absence of full-
length WASP, and that the disadvantage likely occurs through dominant negative competition of WASPDVCA with N-WASP,
a protein that otherwise partially compensates for WASP absence in developing thymocytes.
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Introduction
The cells comprising a multicellular organism reproduce and
compete in particular local environments, much as do free-living
organisms. When genetic differences arise within a cell type,
evolution can ensue within the host organism. The classic example
of this phenomenon is cancer – a somatic mutant arises and
increases in frequency relative to cells of the germ line genotype
due to a selective advantage in the local environment. In cancer,
selection at the level of the cell type differs from selection at the
level of the host organism because the role of the affected cell type
in the multicellular organism is at odds with maximizing the
number of its progeny cells.
We present an instance involving a germ line allele causing
disease at the level of the whole organism. In contrast to cancer
causing mutations, in this situation the somatic mutations that
increase in frequency due to selection at the level of the cell also
confer benefit to the whole organism. This coincident benefit
means that identifying the strength, timing and local environment
in which the somatic mutation(s) confer advantage will contribute
to a better understanding of how the affected cell type normally
functions within the multicellular organism.
For genetic hematopoietic diseases, somatic mutations that are
corrective at the level of the whole organism may have a special
propensity to reach high frequency in the cell population. This is
because a successful somatic mutant with higher fitness relative to
hematopoietic cells carrying the inherited allele has long survival
and a long-term influence on the organism’s fate. In addition,
hematopoietic cells function throughout the body, allowing
compensatory somatic mutants to affect the organism systemi-
cally. However somatic mutations can only benefit the whole
organism to the extent that (i) at the level of the cell type,
selection on a newly arising somatic mutant is strongly positive
and (ii) that selection against the germ line allele occurs early
enough in the cell lineage that sufficient divisions remain for a
mutation-corrected allele to increase in frequency in the cell
population.
Here we describe a situation where the balance of these two
factors is such that not one, but many, somatic mutations are
detected. This occurred independently and in parallel in the T cell
populations of two brothers who share the same germ line
mutation of the gene Wiskott Aldrich Syndrome protein (WASP). We
document these numerous compensatory somatic alleles and
explore the timing, location and the nature of their selective
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3444advantage, thereby deducing that the gene product, also called
WASP, affects T cell populations in at least two distinct contexts.
Wiskott-Aldrich Syndrome (WAS) and WASP Function
Wiskott-Aldrich syndrome (WAS) (MIM #30100) is an X-
linked combined primary immunodeficiency disease [1] causing
bleeding due to thrombocytopenia and numerous immune defects
(reviewed in [2]). Histocompatibility-matched hematopoietic stem
cell transplantation is currently the only cure [3] for WAS. For
patients for whom no histocompatible matched donor is available,
life expectancy is still short, particularly for patients with WASP-
negative mutations [4]. In part for this reason, WAS is among
those conditions for which hematopoietic stem cell gene therapy is
under intense study [5,6].
Immune dysfunction in this disease varies from mild to life-
threatening, depending to a large extent on whether the inherited
mutation supports expression of some level of WASP in the
patient’s blood cells (milder disease) or leads to WASP absence
(severe disease) [4]. In unusual cases, the impact of severe germ
line WASP mutations is mitigated by somatic reversion or somatic
second site mutation [7–13].
WASP couples extracellular stimulation of the cell to rapid
intracellular remodeling of the actin-based cytoskeleton (reviewed
in [14]). WASP is expressed only in white blood cells; its closely
related homolog N-WASP is broadly expressed. Both proteins
assume an autoinhibited (closed) conformation in resting cells [15].
WASP’s function in cytoskeletal rearrangement is best understood
in T lymphocytes. In these cells activation occurs when antigens
bind to the T cell antigen receptor (T cell receptor; TCR). WASP
is then recruited to the newly generated immunological synapse
between the antigen presenting cell and the T cell [16]. At the
immune synapse, activating mediators such as the lipid phosphoi-
nositol 4,5-biphosphate (PIP2) and cdc42, a GTPase, bind to
WASP, releasing autoinhibition and unmasking WASP’s C-
terminal VCA (verprolin homology, cofilin homology, acidic)
domains. The VCA domains cooperate with a complex of actin
related proteins (Arp2/3 complex) to generate new actin filaments
[15,17] that are required for altering cell polarity, proliferative
response and further cell differentiation. Through this process,
WASP is critical for optimal proliferative response of T
lymphocytes and in a similar manner for B lymphocytes. WASP
is also expressed in other white blood cells: monocytes,
neutrophils, NK lymphocytes and platelets, where its actin
remodeling activity contributes to migration, phagocytosis and
other functions (reviewed in [14]).
WASP is also believed to contribute to maturation of progenitor
T and B lymphoid cells. This inference rests on a cross-sectional
study showing that WAS patients have decreased numbers of
mature T and B lymphocytes in their blood relative to age-
matched healthy normal individuals [18]. The deficit of total
blood T and B cells primarily reflects the decrease of the initially
produced antigen-inexperienced ‘‘naı ¨ve’’ T and B cells rather than
antigen-experienced ‘‘memory’’ cells.
The brothers studied here inherited a rare WASP mutation
(G1305 delete) predicted to result in a truncated protein that lacks
the VCA domains (WASPDVCA). Their mother is a confirmed
carrier. As is typical for WAS carriers, her mature blood cells are
normal in number and phenotype, reflecting selective survival
and/or proliferation of progenitor cells with the active X-
chromosome bearing normal WASP [19]. In the three other
patients reported to carry this mutation (two of whom were
maternal uncles of these brothers), the mutation caused severe
WAS [20]. In contrast, the brothers reached adulthood with only
moderate disease. Here we describe their somatic alleles and
investigate their selective advantage in T-lymphopoiesis. Because
during T-lymphopoiesis selection for survival and replication at
the level of the thymocyte is concordant with these cells’ normal
contribution to the whole organism’s phenotype, this selection
sheds light on the normal role of WASP in T-lymphopoiesis.
Results
Identifying Cell Types Experiencing Selection for WASP
Function
To resolve the discordancy of the brothers’ severe germ line
mutation and their moderate disease course, we subjected their
blood cells to quantitative and qualitative analyses. This was done
by staining blood samples with antibodies to cell surface ‘‘marker’’
proteins and analyzing the stained cells by flow cytometry. Table 1
shows the quantitation of their lymphocytes compared to age-
matched normal healthy individuals. The results reflect the
previously described pattern for this disease albeit at the more
extreme end: the brothers share significant deficits of T cells (both
CD4 and CD8) and B cells but have normal numbers of natural
killer cells (NK cells) [18]. In particular, their memory CD4 and
CD8 T cells were in the normal range, but the number of their
naı ¨ve, i.e., antigen-inexperienced, CD4 and CD8 cells were
decreased by more than 75% relative to normal values. Notably,
the patterns in the two brothers are almost identical.
Because cells of previously studied WAS patients with
truncation mutations have revealed little or no WASP [4,21], we
used flow cytometry to determine whether any WASP is expressed
in the brothers’ cells. Peripheral blood mononuclear cells (PBMC)
were permeabilized, stained intracellularly with fluorescent
antibodies to WASP, and analyzed to detect presence vs. absence
of the WASP protein at the level of single cells. Whereas
monocytes of the brothers were WASP-negative, appearing
unstained or dimly stained, their lymphocytes included a minor
population of brightly staining WASP-positive cells (Figure 1A, left
and middle). WASP-positive cells were more prevalent among T
lymphocytes (CD3
+ cells), comprising 56% for the younger
brother (patient 2) (Figure 1A, right) and 58% for his sibling
(patient 1, not shown). Of note, the intensity of fluorescent label,
an approximate measure of WASP density, was comparable for
the WASP-positive subset of patient T cells and normal T cells
Table 1. Lymphocyte Populations in Patient Blood.
Cells Absolute cell count (610
6/ml)
Patient 1 Patient 2 Normal
ab
Total lymphocytes 0.96 1.08 1.68 (1.48–2.00)*
T cells (CD3
+ CD45
+) 0.61 0.67 1.26 (1.04–1.52)*
B cells (CD19
+ CD45
+) 0.04 0.06 0.24 (0.18–0.26)**
NK cells (CD16
+ CD56
+ CD3
2) 0.30 0.20 0.18 (0.13–0.37)
ns
Naı ¨ve CD4 cells (CD45RA
+) 0.09 0.10 0.40 (0.14–0.74)*
Memory CD4 cells (CD45RA
2) 0.32 0.49 0.42 (0.32–0.48)
ns
Naı ¨ve CD8 cells (CD45RA
+CCR7
+) 0.005 0.006 0.22 (0.18–0.34)*
Memory CD8 cells
c 0.165 0.204 0.11 (0.09–0.21)
ns
aNormal values (median;5
th–95
th percentile) for 11 healthy adult males [18].
bSignificance from one-tailed t-tests comparing cell counts of the normal
healthy males to the brothers’ counts:
ns p.0.05; * 0.01,p,0.05; **
0.001,p,0.01.
cMemory CD8 cells are the sum of CD8
+CD45RA
+CCR7
2 and CD8
+CD45RA
2
cells.
doi:10.1371/journal.pone.0003444.t001
Multiple Somatic Alleles
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do so at normal or near normal levels. These T lymphocytes must
either express more truncated WASP than other cells bearing the
same genotype or they are WASP-positive because they bear a
somatic allele.
WASP-positive cells were found in both CD4 and CD8 T-cells
(Figure 1B, left and middle). Antibody to CD45RA, a stage-
specific T cell antigen, was used to distinguish naı ¨ve and memory
cells [22]. WASP-positive cells were frequent among memory CD4
cells (CD45RA
2, upper left quadrant) (65% for patient 1; 70% for
patient 2), but were infrequent (#7%) among naive CD4 cells
(CD45RA
+, upper right quadrant). WASP-positive cells were also
frequent among CD8 memory (CD45RA
2) cells of both patients
(89%, 88%) and infrequent in the small CD8
+CD45RA
+
population that includes the CD8 naı ¨ve cells. NK lymphocytes
(NK cells) were uniformly WASP-negative (Figure 1B, right).
These quantitative findings for the two brothers are compiled in
Figure 1D.
A fraction of B lymphocytes (CD19
+ lymphocytes) were also
WASP-positive, amounting to 7% for patient 2 (Figure 1C, left
and middle) and 4% for patient 1 (not shown). For patient 2, the B
cells were further subdivided. WASP-positive cells were negligible
Figure 1. WASP in Patient Blood Cells Revealed by Flow Cytometry. PBMC of the younger brother (patient 2) were stained intracellularly
with B9 monoclonal antibody to WASP and, where indicated, were stained with surface marker antibodies. (A) Monocytes and lymphocytes. Shown
are patient monocytes (left), total lymphocytes (middle), and T lymphocytes (CD3
+ cells) (right) indicated by filled histograms; cells of a normal
individual are indicated by black outlines and isotype control by green outlines. (B) T and NK lymphocytes. CD4 (CD4
+) and CD8 (CD8
bright) cells, and
NK cells (CD56
+CD3
2) stained for WASP and, where indicated, for CD45RA to distinguish T cell subsets. Numbers within quadrants indicate the
percentage of cells. (C) B-lymphocytes. B cells (CD19
+) were stained with isotype control antibody (left) or WASP antibody (middle, right) and for CD27
to distinguish B-cell subsets (right). (D) Shown are the percent WASP-positive cells in different populations averaged across the two brothers. ND, not
determined.
doi:10.1371/journal.pone.0003444.g001
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but frequent in the CD27-positive cells (42%), which are B cells
that have undergone differentiation and expansion in the
periphery [23,24].
WASP Phenotype in Cell Types under Selection
The patients’ germ line mutation is a single nucleotide deletion in
exon 10 (1305delG) [25]. The expected effect is frameshift and
prematurestopwithinexon10togeneratetruncatedproteinlacking
the VCA domains required for actin remodeling (Figure 2A). To
study the amount and size of the WASP protein in patient cell types
for which flow cytometry data indicated selection on WASP
function, we studied isolated PBMC (lymphocytes plus monocytes),
neutrophils and lymphocytes by Western blot. Unlike flow
cytometry, which compiles data for individual single cells, Western
blot reports on protein isolated from cell populations. The blots
were stained with antibodies directed against different epitopes of
WASP. These are antibodies B9 and D1, directed against epitopes
within the N-terminal 250 amino acids, and W485, an antibody
directed against residues 485-502. All three antibodies detected full
length WASP bands (apparent 63 kDa) in all analyzed blood cells of
normal individuals as anticipated and detected similar size WASP
bands at lower levels in patient PBMC and in lymphocytes but not
in patient neutrophils [26] verified in Figure 2B). In addition, D1
and B9 antibodies detected a weaker band in patient PBMC,
lymphocytes and neutrophils at the approximate position expected
for truncated WASP (apparent 47 kDa). This 47 kDa band was not
foundincellsofnormalPBMC,lymphocytesorneutrophils.Blotsof
patient cells stained with the W485 antibody that reacts with an
epitope at the extreme C-terminus failed to detect the 47 kDa
protein, further indicating that it is truncated WASP. Importantly,
because the patients’ full sizeprotein (,63 kDa)wasdetectedby the
W485 antibody, the sequence at the C-terminus must be encoded
by an allele with an in-frame C-terminal region in contrast with the
inherited allele.
Genetic Basis of Restored Phenotype in Patient T Cells
When mRNA of patient 2 PBMC was reverse transcribed and
amplified, the product was a single band of apparent normal size
and amount (not shown). Both the bulk product and randomly
selected clones had the germ line frameshift-stop sequence.
However, one clone that was non-randomly selected for study
because of its slightly smaller insert coded for WASP with an 18 bp
deletion relative to the normal sequence (17 bp deletion flanking
the germ line nucleotide deletion) (detailed below). This sequence
would be consistent with a somatic second site mutation. On
sequencing another ‘‘small insert’’, we were surprised to find a
different mutation, a 20 bp deletion flanking the germ line
mutation. Although a few instances of multiple somatic mutations
have been described for other primary immune deficiencies no
WAS patient described at that time had more than one somatic
allele (Discussion).
To sequence the somatic mutations, we amplified and cloned
DNA of patient 2 PBMC and T cell DNA of both brothers. A total
of 14 somatic WASP alleles were sequenced and are shown in
Table 2. It is important to note that our cloning effort was not
exhaustive and did not come close to a generating a saturated
sample of the population of alleles coexisting in each brother
(presented later), and so Table 2 should be viewed as a subset of
the brothers’ alleles, which may be biased toward alleles differing
from the germ line allele in length.
The detected somatic alleles are of two types. The most
frequent, found in all 8 clones for patient 2 and in 4 of 11 clones
for patient 1, are deletions that surround the germ line single
nucleotide deletion. These encode WASP lacking 4, 5, 6, 7, 11 or
18 amino acids of the linker polypeptide that separates the proline-
rich region and the verprolin homology domains (Figure 3, top).
The other allele type, small insertions or deletions upstream and in
one case downstream of the germ line mutation, were found in 7 of
11 clones for patient 1. These encode WASP with small out-of-
frame segments and/or deletions that restore the downstream
reading frame (Figure 3, bottom).
Overall, the patients’ somatic alleles are highly diverse at the
DNA level but have common features at the level of encoded
protein. All changes are confined to the linker region, which has
no known function, and limited segments of the large proline-rich
region. Notably, all 14 somatic alleles restore the translational
reading frame encoding the VCA domains required for WASP to
function in actin remodeling in contrast to what would be
expected from a random assortment of somatic mutations
(Figure 3). This strongly suggests that natural selection within
lymphocyte populations favors the survival and proliferation of
cells expressing these VCA domain-restoring alleles over cells
expressing the inherited WASPDVCA allele or somatic mutations
that fail to restore protein function.
Figure 2. WASP in Patient T Cells Revealed by Western Blot. (A)
Schematic of (top) normal WASP (502 amino acids) and (bottom) WASP
encoded by the patients’ germ line mutation (1305delG in exon 10,
arrow) with the frameshifted region (424–443) (fs) indicated. Shown are
the upstream regulatory domains: EVH-1, GBD (GTPase binding), and
proline-rich region (binding sites for adapter proteins and tyrosine
kinases), and the downstream verprolin homology (V) (exon 10), cofilin
homology (C) (exon 11) and acidic (A) (exon 12) domains that function
in generating actin filaments. The intramolecular bond of autoinhibited
WASP is indicated by a dotted line. (B) PBMC, neutrophils and
lymphocytes (5610
5 cells) of normal individuals (N) and patients 1
(P1) and 2 (P2) were stained as indicated with B9 and D1 antibodies to
WASP residues 1–250 and W485 antibody to the C-terminal peptide.
The numbers on the right indicate apparent mass (kDa) of WASP bands
relative to marker proteins. The asterisk (*) in the W485 blot indicates
the position of a 40 kDa marker protein, which was used to verify
inclusion of the 47 kDa region. The blots were restained with actin
antibodies, which verified equal protein loading (not shown).
doi:10.1371/journal.pone.0003444.g002
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Allele# Mutation
a Predicted Effect D Gene length
b Patient Source
c
1 1303–1314del 424–427del 211 bp patient 2 T cell
G
2 1297–1311del 422–426del 214 bp patient 1 T cell
G
3 1295–1312del 421–426del 217 bp patient 1 T cell
G
patient 2 T cell
G, PBMC
R (26)
4 1301–1321del 423–429del 220 bp patient 2 T cell
G
5 1299–1319del 422–428del, G429R 220 bp patient 2 PBMC
R
6 1283–1315del 417–427 232 bp patient 1 T cell
G (26)
7 1275–1328del 415–432del; P414R 253 bp patient 2 T cell
G, PBMC
G
8 1323–24insG 424–429 fs +1 bp patient 1 T cell
G
9 1281–82delCT 417–424fs 22 bp patient 1 T cell
G
10 1257–58insA 409–424fs +1 bp patient 1 T cell
G
11 1243–44ins10bp 404–424fs +10 bp patient 1 T cell
G
12 1218–1261del 396–409del; 410–424fs 244 bp patient 1 T cell
G
13 1211–1239del 393–402del, 403–424fs 229 bp patient 1 T cell
G
14 1113–14insC 361–424fs +1 bp patient 1 T cell
G
aNucleotides and amino acids are numbered relative to normal WASP. Amino acids are identified by single letter code. del, deletion; ins, insertion; fs, frameshift.
bChanges of gene and cDNA length (D Gene length) are expressed relative to the patients’ germ line allele.
cClones indicated by superscript
G were generated from genomic DNA; those indicated by superscript
R were generated from reverse-transcribed RNA. Except where
noted (# 3, 6 and 7), each allele was cloned once.
doi:10.1371/journal.pone.0003444.t002
Figure 3. Fourteen Somatic Patient Alleles Identified by Cloning. Top: Alleles 1–7. Shown is the affected segment of exon 10 of normal WASP
(N), the patients’ germ line allele (G) and somatic alleles #1–7 (identified on the right). The arrow marks the germ line 1305G deletion. These 7 alleles
encode WASP with deletions in the linker region that minimally impinge on the upstream proline-rich region (orange) and do not impinge on the
downstream verprolin homology (V) domain (green). Features favorable to mutations include the high GC content and particularly nucleotides 1299–
1316 (yellow), which may form a hairpin loop stabilized by five G-C bonds, and tandem 4 nucleotide repeats (underlined) that could predispose to
deletion by slipped strand mispairing. Bottom: Alleles # 8–14. Shown is the entire exon 10 with 1305G marked by an arrow. Patient allele #3i s
repeated to facilitate comparison. Deleted segments are shown as black, out-of-frame segments as crosshatched. Numbering is relative to normal
WASP. Further details are in Table 2.
doi:10.1371/journal.pone.0003444.g003
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in vitro
We also studied a B cell line from one of the brothers. This was
an Epstein-Barr virus (EBV) immortalized line generated 9 years
earlier from PBMC of patient 2, who was then 13 years old. When
the cell line was first generated, full length WASP was found by
quantitative Western blot at 15% of normal level [27], but later
assays showed variably higher levels. To assess whether selection
for somatic alleles also occurs in vitro, a remaining aliquot of the
earliest cryopreserved immortalized cells was placed in culture.
Flow cytometry performed 1 week later showed that 1% of cells
were WASP-positive; however by 6 weeks the frequency of WASP-
positive cells had increased to 16% and by 10 weeks to more than
90% (Figure 4A and insert). Nearly identical results were obtained
on culturing a second aliquot of the cryopreserved cells (data not
shown).
Size analysis of amplified exon 10 from the patient cell line at 6
weeks of culture showed a major fragment, 1-bp smaller than
normal, consistent with the germ line allele, and a minor fragment
smaller by 17-bp that represented 15% of amplified DNA
(Figure 4B). The long-term cultured cells had only the latter size
fragment; its sequence is identical to somatic allele #3 identified
for patient T cells. Western blots showed time-dependent increase
of full-length (63 kDa) WASP concurrent with time-dependent
decrease of the 47 kDa apparent truncated WASP protein
(Figure 4C). These findings demonstrate a change in the allele
frequency within the cell line due to natural selection acting
through an in vitro survival and/or proliferation advantage for
WASP gene-corrected B-cells relative to germ line encoded B-cells.
Diversity of Somatic Alleles Expressed in Patient T cells
The WASP protein in patient T cells could have been
transcribed primarily from a single allele if most somatic mutations
persisted in cells and were only occasionally transcribed. To
distinguish between this possibility and that of multiple transcribed
somatic alleles, we subjected amplified reverse-transcribed RNA
and amplified genomic DNA to size analysis by high resolution
electrophoresis. On size analysis, RNA-derived fragments from T
cells and NK cells of normal healthy individuals migrated as single
peaks at the predicted 284 bp (Figure 5, top row, left and middle),
and patient NK-cell fragments migrated as a single 283 bp peak,
consistent with the germ line allele (Figure 5, row 2, left),
indicating that transcribed WASP in these cell populations comes
from a single source allele. In contrast, the results for the patients
clearly showed multiple peaks in T cell genomic DNA and in T
cell RNA (Figure 5 rows 2, 3), demonstrating that ‘‘full length’’
WASP protein detected by Western blot of patient T cells is a
mixture of differently ‘‘corrected’’ WASP proteins synthesized by
cells expressing different somatic alleles.
Through high resolution electrophoresis we also aimed to
describe the diversity of WASP RNA size classes. Densitometry
indicated that 58% of T cell RNA of patient 2 differs in size from
the germ-line allele. This is consistent with the 56% of T cells that
are WASP-positive as identified by flow cytometry. Both his RNA-
and DNA-derived products consisted of discrete peaks that
included the germ line fragment and somatic fragments lacking
8, 11, 14 or 17 bp relative to the germ line fragment. For patient 1,
individual novel peaks were less prominent, consistent with the
greater diversity of this patient’s somatic alleles. The ‘‘germ line’’
Figure 4. Changes in WASP Over Time of Culture of an EBV-transformed B Lymphoblastoid Cell Line of Patient 2. Cryopreserved cells
from the earliest freeze of the transformed cell line were placed in culture and sampled at the indicated times. (A) WASP expression analyzed by flow
cytometry after intracellular staining with B9 WASP antibody or isotype control. The insert shows the relative frequency of WASP
+ and WASP
2
populations on a log scale. (B) Fragment length analysis of amplified exon 10 of a normal B cell line (top), the patient B cell line at 6 weeks (middle)
and after long term culture (bottom). (C) Western blot of cells harvested at 2, 5 or 7 weeks and stained with B9 antibody to reveal full-length (63 kDa)
WASP and 47 kDa truncated WASP.
doi:10.1371/journal.pone.0003444.g004
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insertions and 2 bp deletions, confounding quantitation of the
percent of RNA that is somatic vs. germline. Conservatively, at
least 2 somatic alleles made up 39% of the WASP RNA in T cells
of patient 1.
Of the novel fragment size classes identified for patient 2, two,
the fragments lacking 8 bp relative to the germ line allele and
those lacking 14 bp, are not represented among the patient’s
cloned alleles. The presence of size classes of patient 2 RNA and
genomic DNA that are not accounted for by the cloned alleles
together with broad peaks for patient 1 indicate that the brothers
have additional somatic alleles not identified in the study. These
findings suggest that the identified somatic WASP alleles represent
the ‘‘tip of the iceberg’’ of diversity of the patients’ T cells.
Discussion
Here we document the independent evolution of polymorphic T
cell populations involving many somatic alleles in two brothers
who inherited a frameshift mutation of WASP. As a result of
selection for somatic alleles, the brothers’ lymphocyte compart-
ments are somatic mosaics and their gene-corrected cells are
identifiable by WASP expression. The somatic alleles are
compensatory because they (i) support WASP expression at
approximately normal levels in certain patient cells and (ii) confer
an apparent selective advantage in the generation of memory T
cells and B cells. WASP mRNA in the patients’ T cells had varying
size, indicating that multiple somatic alleles are indeed expressed.
The somatic alleles differed between the two brothers - both in the
type of clones isolated and the fragment length patterns. This
implies a random process at the level of generation of somatic
mutations. In contrast, the quantitative enrichment of somatic
alleles and their distribution among lymphocyte populations were
indistinguishable between the brothers, speaking for the uniformity
of the selection (enrichment) forces.
Somatic alleles were first described for primary immune
deficiency for a patient with adenosine deaminase deficiency
[28] and subsequently for WAS. In general, detection of a somatic
mutation indicates that a new allele provides a differentiation,
growth or survival advantage for the cell population(s) in which it
appears. Historically, somatic alleles have been considered rare,
however results obtained with newer detection methods suggest
that they occur with greater frequency than previously thought, at
least for genetic hematopoietic diseases (as outlined in Introduc-
tion). For example, by testing antibody stained cells by flow
cytometry, an international consortium recently documented
somatic WASP alleles, either reversions or second site mutations,
in 11% of 272 WAS patients [29]. These somatic mutations of
WASP led to a variety of enrichment patterns: T cells only were
most frequent, followed by T plus NK cells or T plus B cells. The
different enrichment patterns are thought to reflect the develop-
mental stage at which the somatic allele arose (stem cell vs.
multipotent progenitor or lineage committed progenitor) and the
importance of WASP in further differentiation, proliferation and
survival of the affected lineage(s). A recent publication reports on
another WAS patient with multiple somatic alleles [30], and thus,
the brothers described here are the second and third reported
cases of multiple somatic alleles in WAS. Although their disease
has features shared with single somatic allele patients, most
notably the preferential enrichment of somatic alleles in memory
T cells [9,10], other important features of their phenotype are
specific to multiple somatic alleles.
Germ Line Allele Confers a Large Cost in T-Cells During
Lymphopoiesis
The unique features of the brothers’ disease are, first of all, the
large number of somatic alleles. Cloning identified 15 alleles, 10
for one brother and 5 for the other. However, the true total is
likely to be much larger as suggested by fragment analysis, which
revealed size classes of alleles that are not present in the clones. A
larger repertoire is also suggested by the paucity of repeat-
isolations of clones with the same sequence, i.e., 15 of 19 clones
had unique sequence, indicating that we have not come close to a
Figure 5. Fragment Length Analysis of Patient mRNA. Messenger RNA of T cells and NK cells was reverse-transcribed, and WASP was amplified
from nucleotide 1151 in exon 10 to 1434 in exon 11, and the products were separated by capillary electrophoresis. Shown are products derived from
RNA of NK cells (left) or T cells (middle) of a normal individual (N) or patient 2 (P2) or T cells of patient 1 (P1). Shown in the right panels are amplified
exon 10 regions of genomic DNA. Fragment lengths (bp) are indicated.
doi:10.1371/journal.pone.0003444.g005
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are diverse. Among those that were cloned, six code for deletions
of varying size (11–53 bp) surrounding the germ line mutation,
four have small indels (+1o r22 bp) at locations ranging from
nucleotide 1113 to nucleotide 1323, and three have deletions or
insertions of 10–44 bp upstream of the inherited mutation.
Whereas diversity is broad, the range of affected cells is narrow
– primarily T cells and to a much smaller extent B cells. Sensitive
techniques of flow cytometry, Western blot, and fragment length
analysis were used to search for somatic alleles in the brothers’
monocytes, neutrophils and NK cells. Only the germ line allele
was found in these cells, indicating that the brothers do not have
genetic instability at the WASP locus. Indeed, based on the
collective findings, there is no reason to postulate that mutation of
WASP in the brothers’ cells occurs at anything other than the
normal random rate. Instead, the much higher rate at which new
somatic alleles have become detectable in these patients indicates a
unique combination of timing and magnitude of selection against
their inherited allele. A further unusual feature of the brothers’
disease is that their blood cells that carry the germ line allele
express truncated WASP. We propose that the multiplicity and
diversity of their somatic alleles relative to other WAS germ line
alleles is due to a deleterious effect of the presence of truncated
WASP over and above the cost of absence of full-length WASP.
Role of WASP Domains in T Cell Lymphopoiesis
Normal hematopoietic precursor cells generated in the bone
marrow migrate to the thymus where they commit to the T-
lineage and undergo programmed differentiation becoming first
CD4/CD8 double negative (DN) thymocytes, then CD4/CD8
double positive (DP) and finally either CD4 single positive (SP) or
CD8 SP thymocytes [31]. These stages differ in transcriptional,
translational, migratory and proliferative activities. In mice, DN
thymocytes are further distinguished as stages 1 (DN1) through 4
(DN4). Progression from DN3 to DN4 and DP depends on
rearrangement of the germ line T cell receptor b-chain (TCR-b)
and expression on the cell surface of pre-TCR (TCR-b associated
with germ line pre-a chain). The TCR a-chain is rearranged in
DP cells and successful rearrangement results in expression of a
unique TCR on DP cells. The specificity of the unique TCR is the
basis for positive selection and those clones that recognize self
peptides in the context of self histocompatibility proteins with
moderate affinity will be selected. The majority of DP cells fail to
recognize self peptides and die by apoptosis. Positively selected DP
cells further mature into SP cells. Both DP and SP cells undergo
negative selection to deplete clones with high affinity for self
antigen (e.g. autoreactive T cell clones); this step is the basis of
central tolerance. Only the small fraction of thymocytes that
survive positive and negative selection emerge from the thymus to
join the pool of peripheral antigen-inexperienced (naı ¨ve) CD4 cells
or CD8 cells. In ideal situations, this pool provides an adequate
number of naı ¨ve T-cells with the broad diversity of TCRs required
for immune protection.
Selection against the Presence of WASPDVCA
An allele similar to the patients’ germ line mutation was
previously studied in mice and found to be extremely deleterious in
T cells. Whereas WAS patients and mice that lack WASP have
modest deficits of T cells [18,32], mice engineered to express
waspDVCA have profoundly decreased numbers of peripheral T
cells and severely decreased thymic cellularity with 12-16% of the
normal number of thymocytes [33]. On analysis of thymocyte
subpopulations, the defect in waspDVCA mice was traced to a
profound block at DN3 thymocytes after TCR-b rearrangement.
The extremely deleterious effect of waspDVCA implies that the
truncated protein interferes with a function crucial to survival of
DN3 thymocytes or their progression to DN4 and DP thymocytes.
Zhang and colleagues postulated that waspDVCA might
interfere with the function of a redundant protein such as N-
WASP or WAVE-2 [33]. N-WASP, WASP and the (three) WAVE
proteins are members of the WASP protein family; each contains a
VCA domain and functions in actin cytoskeletal regulation [34].
We consider the WAVE protein an unlikely candidate because
WASP-WAVE homology is limited to the WASP C-terminal
region. In contrast, N-WASP and WASP share homologies that
include the N-terminal domains retained in WASPDVCA. These
domains function in recruiting WASP/N-WASP to sites of
activation and in binding ligands that convert autoinhibited
WASP/N-WASP to the active form [15,17]. We thus anticipate
that truncated WASPDVCA encoded by the patients’ germ line
allele will retain the ability to bind to effector ligands, potentially
competing with the ability of N-WASP to perform a redundant
function. A dominant block of thymocyte maturation due to
competitive inhibition of N-WASP would provide a strong
selective advantage to a mutation in which the VCA domain is
restored. This makes WASPDVCA a dominant negative mutation
in that the truncated protein interacts with effectors as the wild-
type protein does, but blocks its function.
Supporting evidence for selection against the presence of
WASPDVCA is provided by a recent study in which WASP and
N-WASP were deleted in murine T cells. Whereas deletion of N-
WASP on a wild type background did not alter T cell
development, deletion of both WASP and N-WASP severely
compromised T cell development, producing a phenotype similar
to that of waspDVCA mice, i.e., marked thymic hypocellularity and
reduced number of peripheral T cells with blockage at the level of
DN3 thymocytes [35]. We conclude that for WASP mutations
resulting in no protein expression at all, N-WASP partially
compensates for lack of WASP in supporting the DN3 to DP
transition, but that WASPDVCA, because it expresses the N-
terminal portion of WASP, competes with the ability of N-WASP
to compensate for WASP function.
Thus, we propose that, in addition to the deleterious effects
conferred by the absence of functional WASP, the patients’
thymocytes expressing WASPDVCA encounter a block to differ-
entiation/ proliferation at the human counterpart of the murine
DN3 stage (described above), and the block creates an unusually
strongselectiveadvantageforthymocytesbearing beneficial somatic
mutations. As a result, thymocytes with correcting somatic
mutations increase in frequency as they replicate and progress
through the final double negative stage to become CD4
+CD8
+ DP
thymocytes. Under this hypothesis, the population released to the
periphery as CD4 or CD8 naı ¨ve T cells would be smaller than
normal, but already enriched for correcting alleles.
Of note, the effect of germline WASPDVCA differs quantitatively
between the patients and the mouse model, in that the brothers
have decreased but readily detectable numbers of WASP-negative
circulating T cells whereas waspDVCA mice have a nearly complete
block of mature T cell generation. This discrepancy may reflect a
different effect of WASPDVCA in mice vs. humans. However, it also
needs to be considered that the expression level of waspDVCA in
the mouse transgenic model approximates the normal wasp
expression level. In contrast, the 47 kDa apparent truncated
WASPDVCA protein is present at low levels in patient blood cells
(Figures 1 and 4). Thus the lesser impact on T cell generation in
the patients may be due to lower concentration of potentially
blocking truncated WASP protein, i.e., a quantitative rather than a
qualitative difference.
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The disadvantage for WASPDVCA germ line thymocytes is
apparently enormous since it is sufficient to drive multiple
independent somatic mutations to detectable frequencies. How-
ever, the extent to which any compensatory alleles can increase in
frequency is limited because thymocytes are short-lived interme-
diates in T cell differentiation that lack the capacity for self
renewal. The multiplicity of somatic alleles in the patients’ T cells
and the failure of any one allele to become fixed in the population
are consistent with the selective advantage occurring at a relative
late stage in T cell differentiation and explain why the absolute
number of gene-corrected T cells is not sufficient to fill the naı ¨ve T
cell compartment. Quite apart from mechanistic questions, the
paucity of the patients’ gene-corrected naı ¨ve T cells is a concern
for their immune protection.
Further Selection in the Periphery
The greater frequency of somatic alleles in the brothers’ memory
T-cells compared to naı ¨ve T cells indicates that further selection
occurs after mature SP thymocytes enter the peripheral circulation
as naı ¨ve T cells. Naı ¨ve T cell population size is controlled by thymic
output and access to cytokine survival factors and, to a limited
extent, by cell replication (reviewed in [36]). Thus the selection
against presence of WASPDVCA directly affects this cell popula-
tion. Because memory T cells are generated from naı ¨ve T cells by
antigen-induced differentiation and clonal expansion, differential
clonal expansion, e.g., by selection for cells with functional WASP,
must explain the greater frequency of gene corrected memory T
cells. Such enrichment by differential clonal expansion was
previously identified for an atypical patient, a female with the
genotype of a WAS carrier, but with circulating white blood cells
that werea mixture of WASP-negative and WASP-positive cells due
to failure of early hematopoietic selection. In contrast, memory T
cells of that patient were primarily WASP-positive [37]. This second
selective event occurring in peripheral T cells has been described
also for WAS patients with single somatic alleles (e.g., [9]), and is
consistent with the known role of WASP in antigen receptor
mediated (TCR-mediated) activation of naı ¨ve T cells [16,38,39].
The flip side of the phenomenon that naı ¨ve T cells bearing a
somatic allele are preferentially recruited to become memory T
cells is the selective depletion of gene-corrected naı ¨ve T cells. This
explains why we don’t see somatic allele enrichment in the
standing naı ¨ve T cell population as one might have anticipated
based on the hypothesized processes occurring in the thymus.
From the perspective of immune repertoire, the patients may
simply have two few gene-corrected naı ¨ve T cells for normal
immune protection.
Somatic Alleles in B Cells
B cells were also examined for the presence of somatic alleles,
although the scope of the study was limited by the paucity of B
cells in blood of these patients. Gene-correction was found in B
cells of both brothers at levels sufficient for detection of the protein
by flow cytometry. Moreover, the somatic allele(s) was strongly
enriched in patient memory B cells, 40% of which were WASP-
positive compared to 1% of naı ¨ve B cells. It is unclear whether the
patients’ precursor B cells underwent repeated selection events to
generate more than one somatic allele.
Similarly to a previous report of somatic allele enrichment in a
patient cell line [8], we found that in vitro culture of the patient B cell
line reproducibly resulted in an increase of a somatic allele from 1%
to close to fixation and concurrent depletion of the germ line allele
and the truncated WASP protein. Whether the selected allele that
we identified for the patient B cell line arose in vitro or in vivo cannot
be distinguished. Regardless, these in vitro evolutions demonstrate a
survivaland/orproliferativeadvantageofthesomaticalleleoverthe
germ line allele in competition in cell culture.
Significance of Multiple Somatic Alleles
A principle difference exists between single vs. multiple somatic
alleles. This difference follows directly from population genetic
principles but is not obvious without this evolutionary perspective.
A single somatic corrective allele can be thought of as a ‘‘jackpot’’
effect – a chance mutation occurring sufficiently early in
maturation of a cell lineage(s) in which the germ line allele has a
cost. Each patient with a ‘‘jackpot’’ correction will have a single
somatic allele, but a different correcting allele might be found in
another patient. In contrast, the presence of multiple somatic
alleles in an individual patient indicates that a more deterministic
process is occurring. We therefore compare the brothers with
other well-characterized primary immunodeficient patients for
whom more than one somatic allele was reported.
The first reported case involved the RAG1 gene (Recombination
Activating Gene-1) in a patient with Omenn’s syndrome, a primary
immunodeficiency, and the second the CD3f gene in a patient with
severe combined immunodeficiency (SCID) [40,41]. Each of these
patient’s somatic alleles apparently benefited from a proliferative
advantage relative to the defective germ line allele at a specific stage
of thymocyte development. The gene-corrected cells lacked the
capacity of hematopoietic stem/progenitor cells for self renewal and
unlimited expansion and only partially filled the T cell compart-
ment. We conclude that the presence of multiple somatic alleles in a
primary immunodeficiency patient indicates that (i) a developmen-
tal stage is severely affected by the germ line allele of that patient
and (ii) the affected developmental stage occurs post self-renewal
capacity. Because population size post self-renewal will be large,
many mutations will be present and strong selection will produce
many different compensatory alleles. Based on the underlying
population genetics, one anticipates that this will happen in all
individuals who carry a particular germ line allele. This explains the
similar frequency butdifferent spectrum of somatic alleles inthe two
brothers. A recent report describes another WAS patient for whom
34 somatic alleles were identified [30]. This patient’s germ line
allele, also an exon 10 mutation, is predicted to result in a truncated
WASP protein missing not only the VCA domain but also most of
the proline-rich region. Once the range of cells expressing the
patient’s somatic alleles has been identified and the phenotype of his
germ line allele clarified at the level of the protein and cell, we may
well find that his case is another example of selection against the
presence of truncated WASP. Interestingly, for two cases, the CD3f
patient and the brothers with WAS, truncated protein was found in
patient cells with the germ line mutation. This suggests that (iii)
multiple somatic alleles may indicate that the germ line allele has a
dominant negative effect.
Thus, a finding of multiple somatic alleles in a single individual
serves to ‘‘flag’’ an inherited allele harboring unique information.
It has potential to contribute toward identifying tightly regulated
maturational steps and providing clues to the specific function of
the gene product at the particular developmental stage.
Methods
Patients
Patient 1, a white male, was 25 years old at the time most of
these studies were done. The diagnosis of the WAS was made in
infancy because of petechial hemorrhages and a positive family
history. At 3 years of age a splenectomy was performed because of
persistent thrombocytopenia. His subsequent growth and devel-
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extremities at an early age. During his teenage years he had
recurrent Molluscum contagiosum infection of the eczematous areas of
his skin. At age 16 he developed moderate to severe symmetrical
arthralgias with joint swelling and immune complex uveitis. At age
21 he complained of low back pain. A diagnosis of sacral
osteomyelitis was established, due to Staphylococcus aureus, and
successfully treated with antibiotics.
The brother, patient 2, was 22 years old at the time most of
these studies were done. Appearance of petechiae in the neonatal
period led to the diagnosis of the WAS. A splenectomy was
performed at age 3 years. He continued thereafter, like his brother,
to take daily antibiotic prophylaxis and intravenous gamma
globulin at 4-week intervals. Except for otitis media, he did not
have serious infections. He was admitted to the hospital at age 7
because of severe otitis externa, which was treated with
carbenicillin and gentamycin. He never had significant eczema.
Subsequent to the experimentation reported here, patient 2
developed non-Hodgkin T cell lymphoma. He was successfully
treated by cord blood transplantation.
Cell Analysis and Isolation
Blood samples were collected with informed consent from the
patients and healthy control individuals using acid-citrate-dextrose
(NIH formula A) as anticoagulant under protocols approved by
the Institutional Review Board of the Immune Disease Institute.
The patients in this manuscript have given written informed
consent (as outlined in the PLoS consent form) to publication of
their case details. The blood was examined immediately or after
overnight shipment at ambient temperature. Cell populations were
quantified using the Max-M cell counter (Coulter Corp, Hialeah,
FL) and by flow cytometry after staining aliquots of whole blood
with combinations of marker antibodies as described [18]. To
isolate specific cell populations, the blood was processed by
differential centrifugation as described [26]. Density centrifugation
on Histopaque 1077 (Sigma, St Louis, MO) was used to separate
the peripheral blood mononuclear cells (PBMC) (lymphocytes plus
monocytes) from the neutrophils. Lymphocytes were isolated from
PBMC by depleting monocytes by adherence to serum-coated
plates. Lymphocytes were isolated from PBMC by negative
immunomagnetic selection and natural killer lymphocytes (NK
lymphocytes) were isolated by positive immunomagnetic selection
with CD56 antibody (reagents from Dynal Biotech, Oslo,
Norway).
Flow Cytometry
PBMC (5610
5)i n5 0ml phosphate buffered saline with 1% fetal
calf serum (PBS-FCS) or whole blood (100 ml) were surface-stained
with phycoerythrin (PE) or phycocyanin-5 (PC5)-labeled CD3,
CD19, CD4, CD8, CD16, CD27, CD45RA and CD56, or IgG1
control antibodies (Beckman Coulter, Hialeah, FL) for 15 min at
,22uC. Whole blood was lysed with FACS
TM Lysing Solution
(BD Biosciences, Palo Alto, CA) for 15 min at ,22uC. After
washing with 3 ml PBS-FCS, the cells were incubated in 250 mlo f
Fix/Perm solution (Pharmingen, San Diego, CA) for 20 min on
ice, washed twice, stained with 5 mg/ml of B9 anti-WASP
monoclonal antibody (Santa Cruz, Santa Cruz, CA) or IgG2a
isotype control (Pharmingen) for 30 min on ice, and washed twice
with Perm/Wash solution. The cells were incubated with 10 mg/
ml of fluorescein isothiocyanate- (FITC-) conjugated goat antibody
to mouse IgG2a (Southern Biotechnology, Birmingham, AL) for
30 min, washed twice with Perm/Wash solution, re-suspended in
50 ml PBS and analyzed immediately on the FACS Calibur by
collecting 10,000 cells/sample. Individual cell populations were
separately evaluated by gating based on forward and side scatter
and/or expression of surface markers.
Western Blots
Isolated PBMC, lymphocytes and neutrophils were washed,
treated with protease inhibitors and lysed with an SDS solution
containing 2-mercaptoethanol as described [26]. The lysates were
fractionated by SDS electrophoresis, transferred electrophoreti-
cally to polyvinylidene difluoride (PVDF) membrane, which was
blocked, washed and incubated with affinity-purified rabbit W485
antibody to WASP [27] or mouse D1 or B9 monoclonal antibodies
to WASP (Santa Cruz Biotechnology, Santa Cruz, CA). After
further washes, the membrane was incubated with
125I labeled
goat antibodies to rabbit immunoglobulin or rabbit antibodies to
mouse immunoglobulin [26]. Where indicated, WASP bands were
quantified using the Storm 860 Imager and Image Quant
(Molecular Dynamics, Sunnyvale, CA).
DNA and RNA Analysis
Genomic DNA was isolated using QiaAmp DNA purification
kit (Qiagen, Valencia, CA). WASP exon 10 was amplified for
cloning with intron primers [42], and PCR products were gel-
purified and cloned into pSTBlue-1 (Novagen, Darmstadt,
Germany). RNA was isolated using Trizol (Invitrogen, Carlsbad,
CA) and was reverse-transcribed (2 mgi n2 0ml) with oligo-dT
(1 mg) Superscript II (200 units) (Promega, Madison, WI) at 45uC
for 50 min. WASP cDNA was amplified for cloning from WASP
906 to 1706 with 59-acgacttcattgaggaccag-39 and 5-tgagtgtgaggac-
caggcag-39 (1 mM of each), 2 mM MgSO4, 0.2 mM dNTPs, and
2.5 U Platinum Taq High Fidelity polymerase (Invitrogen) at 95uC
for 2 min, 35 cycles at 95uC for 30 s, 57uC for 30 s, 72uC for
1 min with 10 min extension at 72uC. For high resolution
fragment length analysis, RNA was reverse-transcribed, and
cDNA and also genomic DNA were amplified using 6-carboxy-
fluorescein (FAM) labeled 59-tccagctactggacgttctg-39 together with
unlabeled 59-accagtccctctgagctctg-39 (cDNA) or 59-cttgttcagct-
gaattccctgcag-39 (T-cell genomic DNA) or 59-tcctgacttagacggga-
cac-39 (B-cell genomic DNA). The products were separated by
capillary electrophoresis
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